LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 41 filers reported holding LEAP THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,360 | -24.4% | 4,000,000 | 0.0% | 0.08% | -19.0% |
| Q4 2022 | $1,800 | -99.9% | 4,000,000 | 0.0% | 0.10% | -33.3% |
| Q3 2022 | $3,520,000 | -23.5% | 4,000,000 | 0.0% | 0.15% | -39.0% |
| Q2 2022 | $4,600,000 | -34.3% | 4,000,000 | 0.0% | 0.25% | -16.0% |
| Q1 2022 | $7,000,000 | -46.0% | 4,000,000 | 0.0% | 0.29% | -16.8% |
| Q4 2021 | $12,960,000 | -19.2% | 4,000,000 | 0.0% | 0.35% | -1.9% |
| Q3 2021 | $16,040,000 | +226.0% | 4,000,000 | +33.3% | 0.36% | +259.0% |
| Q2 2021 | $4,920,000 | -13.7% | 3,000,000 | 0.0% | 0.10% | -1.0% |
| Q1 2021 | $5,700,000 | -15.6% | 3,000,000 | 0.0% | 0.10% | -30.3% |
| Q4 2020 | $6,750,000 | +20.7% | 3,000,000 | +6.2% | 0.14% | +6.6% |
| Q3 2020 | $5,594,000 | -10.0% | 2,825,300 | -5.0% | 0.14% | -21.8% |
| Q2 2020 | $6,216,000 | +1473.7% | 2,974,000 | +1089.6% | 0.17% | +923.5% |
| Q1 2020 | $395,000 | – | 250,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 900,733 | $1,883,000 | 1.44% |
| Sio Capital Management, LLC | 1,501,998 | $3,139,000 | 0.92% |
| CVI Holdings, LLC | 704,900 | $1,473,000 | 0.55% |
| Perceptive Advisors | 8,476,496 | $17,466,000 | 0.28% |
| Artal Group S.A. | 2,974,000 | $6,216,000 | 0.17% |
| SPHERA FUNDS MANAGEMENT LTD. | 880,000 | $1,839,000 | 0.17% |
| DAFNA Capital Management LLC | 275,000 | $575,000 | 0.17% |
| J. Goldman & Co LP | 1,018,285 | $2,128,000 | 0.13% |
| MYDA Advisors LLC | 100,000 | $209,000 | 0.13% |
| 683 Capital Management, LLC | 526,466 | $1,100,000 | 0.09% |